The document discusses treatment for epilepsy through anti-epileptic drugs (AEDs). It explains that the main mechanisms of action for AEDs include blocking sodium channels, inhibiting calcium currents, enhancing GABA, and blocking glutamate. It provides examples of specific AEDs that work through each of these mechanisms, such as carbamazepine which blocks sodium channels and valproate which inhibits calcium currents and enhances GABA. It also discusses using AEDs to treat status epilepticus.
The document discusses treatment for epilepsy through anti-epileptic drugs (AEDs). It explains that the main mechanisms of action for AEDs include blocking sodium channels, inhibiting calcium currents, enhancing GABA, and blocking glutamate. It provides examples of specific AEDs that work through each of these mechanisms, such as carbamazepine which blocks sodium channels and valproate which inhibits calcium currents and enhances GABA. It also discusses using AEDs to treat status epilepticus.
The document discusses treatment for epilepsy through anti-epileptic drugs (AEDs). It explains that the main mechanisms of action for AEDs include blocking sodium channels, inhibiting calcium currents, enhancing GABA, and blocking glutamate. It provides examples of specific AEDs that work through each of these mechanisms, such as carbamazepine which blocks sodium channels and valproate which inhibits calcium currents and enhances GABA. It also discusses using AEDs to treat status epilepticus.
The document discusses treatment for epilepsy through anti-epileptic drugs (AEDs). It explains that the main mechanisms of action for AEDs include blocking sodium channels, inhibiting calcium currents, enhancing GABA, and blocking glutamate. It provides examples of specific AEDs that work through each of these mechanisms, such as carbamazepine which blocks sodium channels and valproate which inhibits calcium currents and enhances GABA. It also discusses using AEDs to treat status epilepticus.
Epilepsy (2) By Dr. Mahmoud Hussien Salih MBBS- MRCP- clinical MD internal medicine. MD neurology
2020 Contents:
◼ How do we treat epilepsy?
➢ Mechanism of action of anti Epileptic Drugs. ➢ Specific AEDs ◼ status Epilepticus. Treatment Anti Epileptic Medications ( first line) Sodium Valproate Carbamazepine Broad-spectrum Narrow spectrum
Active against generalized and Active against focal seizures
focal seizures
Active against photosensitive More effective in foal seizure than
seizure valproate
Unlikely to be the first line drug May exacerbate generalized
for female approaching child seizures bearing age Mechanism of action:
◼ The main groups include:
➢ Sodium channel blockers. ➢ Calcium current inhibitors. ➢ GABA enhancers. ➢ Glutamate blockers. 1.Sodium channel blockers ◼ EDs that target the sodium channels prevent the return of these channels to the active state by stabilizing them in the inactive state. In doing so, they prevent repetitive firing of the axons. ◼ Sodium channel blockers are : ➢ Carbamazepine ➢ Phenytoin ➢ Lamotrigine 2.Calcium channel blockers ◼ Calcium channels function as the " pacemakers " of normal rhythmic brain activity. This is particularly true of the thalamus. ◼ T-calcium channels have been known to play a role in absence seizures. ◼ AEDs that inhibit these T-calcium channels are: ➢ Ethosuximide. ➢ Valproate. 3. GABA enhancers ◼ Gamma-aminobutyric acid (GABA) has 2 types of receptors, A and B. ◼ When GABA binds to a GABA-A receptor, the passage of chloride, a negatively charged ion, into the cell is facilitated via chloride channels. ◼ This influx of chloride increases the negativity of the cell ( a more negative resting membrane potential). ◼ This causes the cell to have greater difficulty reaching the action potential. ◼ The GABA system can be enhanced by : ➢ binding directly to GABA-A receptors ➢ blocking presynaptic GABA uptake ➢ inhibiting the metabolism of GABA by GABA transaminase ➢ increasing the synthesis of GABA. ◼ GABA is produced by decarboxylation of glutamate mediated by the enzyme glutamic acid decarboxylase (GAD). Some AEDs may act as modulators of this enzyme, enhancing the production of GABA and down-regulating glutamate . ◼ Some AEDs function by blocking the reuptake of GABA (tiagabine [TGB]) or by inhibiting its metabolism by GABA transaminase (vigabatrin [VGB]), resulting in increased accumulation of GABA at the postsynaptic receptors. 4. Glutamate blockers ◼ Glutamate receptors bind glutamate, an excitatory amino acid neurotransmitter. Upon binding glutamate, the receptors facilitate the flow of both sodium and calcium ions into the cell, resulting in excitation.